Ismail Abdulrahman Al-Badawi

Jan 13, 2024 | mdpi.com | Ismail Abdulrahman Al-Badawi |Ahmed Abu-Zaid |osama alomar |Mohannad Alsabban

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Aug 17, 2023 | mdpi.com | osama alomar |Mohammed Jamjoom |Ismail Abdulrahman Al-Badawi |Saud Owaimer Alsehaimi

1. IntroductionOvarian cancer is a difficult disease to manage due to its aggressive nature and high recurrence rates. Despite advancements in diagnosis and treatment, it remains a leading cause of cancer-related deaths in women in the United States. This gynecologic cancer originates in the ovaries and is often diagnosed at an advanced stage. In 2021, around 22,000 women were estimated to be diagnosed with ovarian cancer in the United States, resulting in over 13,000 deaths.